BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33170206)

  • 1. Response to Jia and Wang.
    Liu X; Liu Q; Yao X; Zhang M; Cui C; Li H; Liu D
    Clin Infect Dis; 2021 Jul; 73(2):352-353. PubMed ID: 33170206
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation.
    Shepherd J; Cooper K; Harris P; Picot J; Rose M
    Health Technol Assess; 2016 Apr; 20(34):1-222. PubMed ID: 27135404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children.
    Kyvsgaard N; Mikkelsen TS; Thastum M; Christensen AE; Wehner PS; Nysom K; Herlin T
    PLoS One; 2019; 14(7):e0219539. PubMed ID: 31295288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for the use of methotrexate in juvenile idiopathic arthritis.
    Niehues T; Lankisch P
    Paediatr Drugs; 2006; 8(6):347-56. PubMed ID: 17154642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.
    Ramanan AV; Dick AD; Jones AP; Hughes DA; McKay A; Rosala-Hallas A; Williamson PR; Hardwick B; Hickey H; Rainford N; Hickey G; Kolamunnage-Dona R; Culeddu G; Plumpton C; Wood E; Compeyrot-Lacassagne S; Woo P; Edelsten C; Beresford MW
    Health Technol Assess; 2019 Apr; 23(15):1-140. PubMed ID: 31033434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting.
    Ferrara G; Mastrangelo G; Barone P; La Torre F; Martino S; Pappagallo G; Ravelli A; Taddio A; Zulian F; Cimaz R;
    Pediatr Rheumatol Online J; 2018 Jul; 16(1):46. PubMed ID: 29996864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents.
    Lurati A; Pontikaki I; Teruzzi B; Desiati F; Gerloni V; Gattinara M; Cimaz R; Fantini F
    Arthritis Rheum; 2006 May; 54(5):1602-7. PubMed ID: 16646003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexate.
    Moncrieffe H; Bennett MF; Tsoras M; Luyrink LK; Johnson AL; Xu H; Dare J; Becker ML; Prahalad S; Rosenkranz M; O'Neil KM; Nigrovic PA; Griffin TA; Lovell DJ; Grom AA; Medvedovic M; Thompson SD
    Rheumatology (Oxford); 2017 Sep; 56(9):1542-1551. PubMed ID: 28582527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial).
    Ramanan AV; Dick AD; Benton D; Compeyrot-Lacassagne S; Dawoud D; Hardwick B; Hickey H; Hughes D; Jones A; Woo P; Edelsten C; Beresford MW;
    Trials; 2014 Jan; 15():14. PubMed ID: 24405833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
    Horneff G; De Bock F; Foeldvari I; Girschick HJ; Michels H; Moebius D; Schmeling H;
    Ann Rheum Dis; 2009 Apr; 68(4):519-25. PubMed ID: 18413440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Response to Tumor Necrosis Factor Inhibitors and Methotrexate Monotherapy in Adults With Juvenile Idiopathic Arthritis: Data From NOR-DMARD.
    Bardan I; Fagerli KM; Sexton J; Kvien TK; Bakland G; Mielnik P; Hu Y; Lien G; Flatø B; Molberg Ø; Kristianslund EK; Aga AB
    J Rheumatol; 2023 Apr; 50(4):538-547. PubMed ID: 36379571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Methotrexate Intolerance in Children With Morphea.
    McColl J; Laxer RM; Pope E; Sibbald C
    J Pediatr Pharmacol Ther; 2023; 28(6):559-564. PubMed ID: 38130351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based cohort study on the risk of malignancy in East Asian children with juvenile idiopathic arthritis.
    Kok VC; Horng JT; Huang JL; Yeh KW; Gau JJ; Chang CW; Zhuang LZ
    BMC Cancer; 2014 Aug; 14():634. PubMed ID: 25174953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis.
    Hinks A; Moncrieffe H; Martin P; Ursu S; Lal S; Kassoumeri L; Weiler T; Glass DN; Thompson SD; Wedderburn LR; Thomson W
    Ann Rheum Dis; 2011 Aug; 70(8):1395-400. PubMed ID: 21515602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate treatment affects effector but not regulatory T cells in juvenile idiopathic arthritis.
    Bulatović Ćalasan M; Vastert SJ; Scholman RC; Verweij F; Klein M; Wulffraat NM; Prakken BJ; van Wijk F
    Rheumatology (Oxford); 2015 Sep; 54(9):1724-34. PubMed ID: 25877908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate therapy associated with a reduced rate of new-onset uveitis in patients with biological-naïve juvenile idiopathic arthritis.
    van Straalen JW; Akay G; Kouwenberg CV; de Roock S; Kalinina Ayuso V; Wulffraat NM; de Boer J; Swart JF
    RMD Open; 2023 Apr; 9(2):. PubMed ID: 37094979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of the immune response mediator genes’ polymorphic variants with the methotrexate efficacy in juvenile idiopathic arthritis.
    Nazarova L; Danilko K; Malievsky V; Karimov D; Bakirov A; Viktorova T
    Turk J Med Sci; 2020 Jun; 50(4):1038-1047. PubMed ID: 31958219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation of the methotrexate in rheumatoid arthritis knowledge questionnaire (MiRAK) for use with parents of children with juvenile idiopathic arthritis: a qualitative study.
    Wickwar S; Buerkle K; McBain H; Ciciriello S; Osborne RH; Wedderburn LR; Newman SP
    Pediatr Rheumatol Online J; 2013 Jul; 11(1):27. PubMed ID: 23822803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Nordic screening guideline for juvenile idiopathic arthritis-related uveitis.
    Leinonen S
    Acta Ophthalmol; 2023 Jun; 101(4):465-468. PubMed ID: 36458735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of transient elastography to assess hepatic steatosis and fibrosis in patients with juvenile idiopathic arthritis during methotrexate treatment.
    Niyasom C; Soponkanaporn S; Vilaiyuk S; Lertudomphonwanit C; Getsuwan S; Tanpawpong P; Kaewduang P; Sobhonslidsuk A
    Clin Rheumatol; 2024 Jan; 43(1):423-433. PubMed ID: 38062311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.